Medunik USA, member of Duchesnay Pharmaceutical Group (DPG) one of the few anchor companies selected by the Government of Canada for its Global Hypergrowth Project, is pleased to announce that Pheburane® coverage has reached another important milestone to the benefit…
Major MS Data Presented at ECTRIMS: Long-Term OCREVUS Safety Confirmed; Fenebrutinib Phase II Shows Near-Complete Disease Suppression Introduction At the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Barcelona, Roche presented a substantial…
Major Step Forward in Endocrine-Resistant Breast Cancer Treatment Roche has announced positive results from its Phase III evERA study, signaling a potential new treatment option for patients with Estrogen Receptor-positive (ER+), HER2-negative advanced or metastatic breast cancer whose disease has…
Your choices can be overwhelming. You’ve got over a dozen options to pick from — each with its pros and cons. When it comes right down to it, the best birth control is the method you’re most likely to use. But…
It can be hard finding back pain treatments that offer lasting relief, or any relief. That’s why a surprising new study, published Wednesday, is drawing public and clinical attention, showing that adults with disabling low-back pain who completed just eight…
Losing Weight Fast“Lose 10 Pounds in 10 Days!” “Eat as Much as You Want — and Still Lose Weight!” “Drop One Dress Size a Day!” Rapid weight loss can seem easy if you believe these advertising claims. Fad diets and…